Balance Sheet Data

Emmaus Life Sciences, Inc. (EMMA)

$0.13

+0.02 (+18.18%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 3.2529.702.492.282.0275.89381.271,915.479,623.0948,345.14
Total Cash (%)
Account Receivables 0.062.150.201.040.384.1020.61103.54520.172,613.28
Account Receivables (%)
Inventories -7.977.094.392.3823.07115.89582.212,924.9414,694.53
Inventories (%)
Accounts Payable 0.357.282.022.583.7918.5193.02467.302,347.6711,794.40
Accounts Payable (%)
Capital Expenditure -0.06-0.06-26.17-0.07-0.03-21.79-109.48-550.03-2,763.27-13,882.33
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.